About us
Karin Lykke-Hartmann, CEO
Founder of iNotify, Karin Lykke-Hartmann, is professor in reproductive medicine at Aarhus University, Denmark, and an expert in reproductive science and translational medicine.
Karin’s long and fervid interest in ovarian follicle development has resulted in an extensive international network and a widely acknowledged in-depth understanding of the molecular mechanisms underlying the transformation of an early dormant follicle into a mature and fertile egg.
UNDERLYING RESEARCH
Relevant scientific publications:
Amoushahi & Lykke-Hartmann, Front Cell Dev Biol, 2021
Distinct Signaling Pathways Distinguish in vivo From in vitro Growth in Murine Ovarian Follicle Activation and Maturation.
Steffensen et al., Front Cell Dev Biol, 2018
Transcripts Encoding the Androgen Receptor and IGF-Related Molecules Are Differently Expressed in Human Granulosa Cells From Primordial and Primary Follicles.
Ernst & Lykke-Hartmann, J Assist Reprod Genet, 2018
Transcripts encoding free radical scavengers in human granulosa cells from primordial and primary ovarian follicles.
Ernst et al., Hum Reprod, 2018
Granulosa cells from human primordial and primary follicles show differential global gene expression profiles.
Mission
Novel treatment paradigm for infertile women
Through targeting of the early and hormone-independent phase of egg maturation, we aim at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy.